Ascendis Pharma A/S Finished Goods
Ascendis Pharma A/S (ASND) had Finished Goods of EUR 28.96 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:FinishedGoods · last filed 2026-02-11
- 2025-12-31: Finished Goods 28.96M EUR.
- 2024-12-31: Finished Goods 42.33M EUR.
- 2023-12-31: Finished Goods 19.34M EUR.
- 2022-12-31: Finished Goods 8.17M EUR.
| Period end | Finished Goods |
|---|---|
| 2025-12-31 | 28.96M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 42.33M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 19.34M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 8.17M EUR 20-F · filed 2024-02-07 |
| 2021-12-31 | 4.29M EUR 20-F · filed 2023-02-16 |